Terms: = Leukemia AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
178 results:
1. Inhibition of nrf2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid leukemia.
Jebanesan DZP; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Das S; Bijukumar NK; Balakrishnan B; Mathews V; Velayudhan SR; Balasubramanian P
Ann Hematol; 2024 Jun; 103(6):1919-1929. PubMed ID: 38630133
[TBL] [Abstract] [Full Text] [Related]
2. Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death.
Mantione ME; Meloni M; Sana I; Bordini J; Del Nero M; Riba M; Ranghetti P; Perotta E; Ghia P; Scarfò L; Muzio M
Cell Death Dis; 2024 Mar; 15(3):224. PubMed ID: 38494482
[TBL] [Abstract] [Full Text] [Related]
3. Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the nrf2 Signaling Pathway in Acute Myeloid leukemia Cells.
Jramne-Saleem Y; Danilenko M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396960
[TBL] [Abstract] [Full Text] [Related]
4. PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway.
Gu H; Chen C; Hou ZS; He XD; Xie S; Ni J; Qian C; Cheng X; Jiang T; Yang C; Roberts TM; Zheng J; Varner JA; Armstrong SA; Zhao JJ
Blood; 2024 May; 143(19):1965-1979. PubMed ID: 38271660
[TBL] [Abstract] [Full Text] [Related]
5. Activation of APE1 modulates nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy.
Diao J; Fan H; Zhang J; Fu X; Liao R; Zhao P; Huang W; Huang S; Liao H; Yu J; Pan D; Wang M; Xiao W; Wen X
Int Immunopharmacol; 2024 Feb; 128():111529. PubMed ID: 38244516
[TBL] [Abstract] [Full Text] [Related]
6. Venetoclax and Hypomethylating Agent Combination in Myeloid Malignancies: Mechanisms of Synergy and Challenges of Resistance.
Mishra R; Zokaei Nikoo M; Veeraballi S; Singh A
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203655
[TBL] [Abstract] [Full Text] [Related]
7. Biogenesis of Mitochondria in Multipotent Mesenchymal Stromal Cells in Patients with Acute leukemia.
Sadovskaya AV; Petinati NA; Sats NV; Drize NI; Vasil'eva AN; Aleshina OA; Parovichnikova EN
Bull Exp Biol Med; 2023 Dec; 176(2):283-289. PubMed ID: 38194072
[TBL] [Abstract] [Full Text] [Related]
8. Dual role of nrf2/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells.
Chen Z; Zhu Q; Qi X; Yang LR; Rong YX; Wei Q; Wu SQ; Lu QW; Li L; Jiang MD; Qi H
Phytomedicine; 2024 Feb; 124():155288. PubMed ID: 38183698
[TBL] [Abstract] [Full Text] [Related]
9. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-nrf2 signaling pathway in chronic myeloid leukemia cells.
Xia Q; Xie J; Zhang J; Zhang L; Zhou Y; Zhu B; Wu Y; Yang Z; Li J
Chem Biol Interact; 2024 Jan; 387():110819. PubMed ID: 38000454
[TBL] [Abstract] [Full Text] [Related]
10. Targeting the NF-E2-related factor 2 pathway for overcoming leukemia.
Harifi-Mood MS; Daroudi M; Darroudi M; Naseri K; Samarghandian S; Farkhondeh T
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127594. PubMed ID: 37890739
[TBL] [Abstract] [Full Text] [Related]
11. Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in nrf2-deficient mice.
Duarte TL; Lopes M; Oliveira M; Santos AG; Vasco C; Reis JP; Antunes AR; Gonçalves A; Chacim S; Oliveira C; Porto B; Teles MJ; Moreira AC; Silva AMN; Schwessinger R; Drakesmith H; Henrique R; Porto G; Duarte D
Leukemia; 2024 Jan; 38(1):96-108. PubMed ID: 37857886
[TBL] [Abstract] [Full Text] [Related]
12. Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
Hirasawa I; Odagiri H; Park G; Sanghavi R; Oshita T; Togi A; Yoshikawa K; Mizutani K; Takeuchi Y; Kobayashi H; Katagiri S; Iwata T; Aoki A
PLoS One; 2023; 18(10):e0292267. PubMed ID: 37851686
[TBL] [Abstract] [Full Text] [Related]
13. The Supplementation of
Gavia-García G; Hernández-Álvarez D; Arista-Ugalde TL; Aguiñiga-Sánchez I; Santiago-Osorio E; Mendoza-Núñez VM; Rosado-Pérez J
Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836390
[TBL] [Abstract] [Full Text] [Related]
14. Duality of Valproic Acid Effects on Inflammation, Oxidative Stress and Autophagy in Human Eosinophilic Cells.
Uzel G; Oylumlu E; Durmus L; Ciraci C
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686250
[TBL] [Abstract] [Full Text] [Related]
15. Targeted Silencing of nrf2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Khodakarami A; Kashani MA; Nazer A; Kheshti AM; Rashidi B; Karpisheh V; Masjedi A; Abolhasani S; Izadi S; Bagherifar R; Hejazian SS; Mohammadi H; Movassaghpour A; Feizi AAH; Hojjat-Farsangi M; Jadidi-Niaragh F
Cell Commun Signal; 2023 Aug; 21(1):188. PubMed ID: 37528446
[TBL] [Abstract] [Full Text] [Related]
16. Tangeretin and 4'-demethyltangeretin prevent damage to mouse hepatocytes from oxidative stress by activating the nrf2-related antioxidant pathway via an epigenetic mechanism.
Su ZY; Chien JC; Tung YC; Wu TY; Liao JA; Wei GJ
Chem Biol Interact; 2023 Sep; 382():110650. PubMed ID: 37517432
[TBL] [Abstract] [Full Text] [Related]
17. ATO Increases ROS Production and Apoptosis of Cells by Enhancing Calpain-Mediated Degradation of the Cancer Survival Protein TG2.
Jambrovics K; Póliska S; Scholtz B; Uray IP; Balajthy Z
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446117
[TBL] [Abstract] [Full Text] [Related]
18. Identification of nrf2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.
Villa-Morales M; Pérez-Gómez L; Pérez-Gómez E; López-Nieva P; Fernández-Navarro P; Santos J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373496
[TBL] [Abstract] [Full Text] [Related]
19. SARS-CoV-2 Inhibits nrf2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection.
Qu Y; Haas de Mello A; Morris DR; Jones-Hall YL; Ivanciuc T; Sattler RA; Paessler S; Menachery VD; Garofalo RP; Casola A
Microbiol Spectr; 2023 Jun; 11(3):e0037823. PubMed ID: 37022178
[TBL] [Abstract] [Full Text] [Related]
20. Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs.
Samarin J; Fabrowski P; Kurilov R; Nuskova H; Hummel-Eisenbeiss J; Pink H; Li N; Weru V; Alborzinia H; Yildiz U; Grob L; Taubert M; Czech M; Morgen M; Brandstädter C; Becker K; Mao L; Jayavelu AK; Goncalves A; Uhrig U; Seiler J; Lyu Y; Diederichs S; Klingmüller U; Muckenthaler M; Kopp-Schneider A; Teleman A; Miller AK; Gunkel N
Redox Biol; 2023 Jun; 62():102639. PubMed ID: 36958250
[TBL] [Abstract] [Full Text] [Related]
[Next]
